Immune Therapy Drug Prolongs Survival in Advanced Lung Cancer Patients

A newly published study involving patients with advanced non-small cell lung cancer resistant to chemotherapy has found a promising weapon in an immune therapy drug commonly used to treat other cancers. The findings were published December 19 in The Lancet and presented at the 2015 annual conference of the European Society for Medical Oncology in […]
The post Immune Therapy Drug Prolongs Survival in Advanced Lung Cancer Patients appeared first on SciTech Daily.